Anthropic’s $16.8B quarter, $1.5T IPO talk

Fine Print: 6 takes for Friday

The detail underneath this week’s headlines.

Fine Print is our Friday format: six short takes, each opening with a number and what it measures. Back means it happened. Ahead means it may.

$16.8 billion: Anthropic’s third-quarter revenue, as told to prospective IPO investors · back

Anthropic told prospective investors at a private meeting in San Francisco on Wednesday that third-quarter revenue was $16.8 billion, Bloomberg reported, citing people familiar with the matter. The Wall Street Journal put the increase at 45% from the prior quarter. Reuters gave the second-quarter figure as $11.6 billion and said Anthropic told investors it was profitable on an adjusted basis. Reuters also reported 2025 revenue of nearly $4.6 billion and an operating loss of more than $8 billion that excludes certain liability writedowns. The third-quarter figure is what the company told investors in a private meeting.

For more company information, recent coverage, and available market data, visit Anthropic on Augment.

About $1.5 trillion: the valuation some investors discussed for Anthropic’s proposed November share sale · ahead

Reuters reported late Thursday that some investors discussed a valuation of about $1.5 trillion, down from the roughly $2 trillion previously floated. Reuters did not name the investors. The figure is not an announced or agreed valuation, and the report does not say Anthropic has accepted a lower number. Reuters said some investors were disappointed by slower sequential growth, and The Information reported that the company described its growth as rapid but slowing. The same Reuters report says Anthropic has committed to spend at least $518 billion over ten years on cloud services, computing and infrastructure. Commitments are contracted obligations, not cash or revenue. CoreWeave’s shares and bonds fell the same week, per Bloomberg. CoreWeave is a public cloud provider and Anthropic develops models, so the businesses differ in cost structure and capital needs.

$25 billion: Reflection AI’s last reported pre-money valuation, as Nvidia weighs buying it · ahead

The Financial Times reported that Nvidia is in early talks about Reflection AI, the open-weight model developer, with three routes under discussion: an outright purchase, a larger stake possibly paired with a bigger chip and compute supply deal, or an acquihire of its staff with a license to its technology. SiliconANGLE’s account says people familiar with the matter told the FT an agreement could come within weeks, and that the talks could still collapse. Reflection’s CEO told CNBC in April that its latest round closed at a $25 billion pre-money valuation, per SiliconANGLE. Nvidia led a $2 billion round in October 2025 and has invested about $800 million in total, per the FT. Neither company has commented publicly.

20%: the cap the SEC proposed on performance fees for registered funds and business development companies · ahead

On September 30 the SEC issued two rule proposals and five notices on private-market access, per Proskauer’s summary. None is final or effective. Under the fee proposal, registered funds and business development companies could pay performance fees of up to 20% of net capital gains or appreciation, including unrealized gains, with written board findings. A companion proposal would generally treat accredited investors as “qualified clients” under Advisers Act Rule 205-3, and interval funds could defer their first repurchase offer by up to two years. The package also covers the FINRA exam and professional credentials as routes to accredited-investor status. The SEC did not propose to change Section 3(c)(7), so individuals in those funds generally still need $5 million in investments. Each item has a 60-day comment period that starts when it is published in the Federal Register.

$870 million: TypeSafe AI’s Series A, at a reported $7.5 billion valuation · back

Andreessen Horowitz led the round, with Sequoia Capital, existing investor DCVC and angel investors participating, per Pulse 2, and Martin Casado is joining the board. TypeSafe builds Jev, a platform for creating and deploying AI applications, and says about a third of Fortune 500 companies use it. That figure is a company claim, and the announcement does not define “using.” Crunchbase News ranked the round second among the week’s ten largest, behind a $2 billion raise by Axiom Solutions International, and lists the valuation as reported.

$16: Iambic Therapeutics priced its Nasdaq IPO at the midpoint of its range · back

Iambic sold 9.4 million shares at $16, raising $150 million, according to Renaissance Capital. The indicated range was $15 to $17, and the terms implied a valuation above $800 million. The Nvidia-backed company is in Phase 1 and uses an AI platform to develop small-molecule cancer drugs.

Augment and/or its affiliates hold a position in Anthropic.

Reported private-company financials and secondary-market indications may be unaudited, incomplete, non-standard, or based on limited transaction activity. They should not be relied upon as fair value, executable pricing, or a basis for any investment decision.